Effective vancomycin concentrations in children: a cross-sectional study
ABSTRACT Objective Analyze the microbiological effectiveness, based on the pharmacokinetics/pharmacodynamics correlation of vancomycin in pediatric patients, and to propose dose adjustment. Methods This is an observational, cross-sectional study, conducted in a pediatric hospital, over a 1-year...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
|
Series: | Einstein (São Paulo) |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082019000100211&lng=en&tlng=en |
id |
doaj-9ec4ee6b6b344b2aaa6240aa097d608b |
---|---|
record_format |
Article |
spelling |
doaj-9ec4ee6b6b344b2aaa6240aa097d608b2020-11-24T22:26:11ZengInstituto Israelita de Ensino e Pesquisa Albert EinsteinEinstein (São Paulo)2317-638517110.31744/einstein_journal/2019ao4396S1679-45082019000100211Effective vancomycin concentrations in children: a cross-sectional studyGeisa Cristina da Silva AlvesFarah Maria Drumond ChequerCristina SanchesABSTRACT Objective Analyze the microbiological effectiveness, based on the pharmacokinetics/pharmacodynamics correlation of vancomycin in pediatric patients, and to propose dose adjustment. Methods This is an observational, cross-sectional study, conducted in a pediatric hospital, over a 1-year period (2016 to 2017). Children of both sexes, aged 2 to 12 years, were included in the study; burn children, and children in renal replacement therapy were excluded. For the pharmacokinetic analysis, two samples of 2mL of whole blood were collected, respecting the 2-hour interval between each withdrawal. Results Ten pediatric patients with median age of 5.5 years and interquartile range (IQR) of 3.2-9.0 years, median weight of 21kg (IQR: 15.5-24.0kg) and median height of 112.5cm (IQR: 95-133cm), were included. Only one child achieved trough concentrations between 10µg/mL and 15µg/mL. Conclusion The empirical use of vancomycin in the children studied did not achieve the therapeutic pharmacokinetic/pharmacodynamic target for minimum inhibitory concentration of 1µg/mL.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082019000100211&lng=en&tlng=enTestes de sensibilidade microbianaFarmacocinéticaAções farmacológicasVancomicinaCriança |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Geisa Cristina da Silva Alves Farah Maria Drumond Chequer Cristina Sanches |
spellingShingle |
Geisa Cristina da Silva Alves Farah Maria Drumond Chequer Cristina Sanches Effective vancomycin concentrations in children: a cross-sectional study Einstein (São Paulo) Testes de sensibilidade microbiana Farmacocinética Ações farmacológicas Vancomicina Criança |
author_facet |
Geisa Cristina da Silva Alves Farah Maria Drumond Chequer Cristina Sanches |
author_sort |
Geisa Cristina da Silva Alves |
title |
Effective vancomycin concentrations in children: a cross-sectional study |
title_short |
Effective vancomycin concentrations in children: a cross-sectional study |
title_full |
Effective vancomycin concentrations in children: a cross-sectional study |
title_fullStr |
Effective vancomycin concentrations in children: a cross-sectional study |
title_full_unstemmed |
Effective vancomycin concentrations in children: a cross-sectional study |
title_sort |
effective vancomycin concentrations in children: a cross-sectional study |
publisher |
Instituto Israelita de Ensino e Pesquisa Albert Einstein |
series |
Einstein (São Paulo) |
issn |
2317-6385 |
description |
ABSTRACT Objective Analyze the microbiological effectiveness, based on the pharmacokinetics/pharmacodynamics correlation of vancomycin in pediatric patients, and to propose dose adjustment. Methods This is an observational, cross-sectional study, conducted in a pediatric hospital, over a 1-year period (2016 to 2017). Children of both sexes, aged 2 to 12 years, were included in the study; burn children, and children in renal replacement therapy were excluded. For the pharmacokinetic analysis, two samples of 2mL of whole blood were collected, respecting the 2-hour interval between each withdrawal. Results Ten pediatric patients with median age of 5.5 years and interquartile range (IQR) of 3.2-9.0 years, median weight of 21kg (IQR: 15.5-24.0kg) and median height of 112.5cm (IQR: 95-133cm), were included. Only one child achieved trough concentrations between 10µg/mL and 15µg/mL. Conclusion The empirical use of vancomycin in the children studied did not achieve the therapeutic pharmacokinetic/pharmacodynamic target for minimum inhibitory concentration of 1µg/mL. |
topic |
Testes de sensibilidade microbiana Farmacocinética Ações farmacológicas Vancomicina Criança |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082019000100211&lng=en&tlng=en |
work_keys_str_mv |
AT geisacristinadasilvaalves effectivevancomycinconcentrationsinchildrenacrosssectionalstudy AT farahmariadrumondchequer effectivevancomycinconcentrationsinchildrenacrosssectionalstudy AT cristinasanches effectivevancomycinconcentrationsinchildrenacrosssectionalstudy |
_version_ |
1725754317091110912 |